InvestorsHub Logo
Followers 13
Posts 4344
Boards Moderated 0
Alias Born 10/27/2020

Re: None

Monday, 11/16/2020 6:07:15 PM

Monday, November 16, 2020 6:07:15 PM

Post# of 18220
Immune Therapeutics company is involved in acquiring the patent for the development of new uses of opioid-related immune- therapies, such as low dose naltrexone (LDN) and Methionine [Met5]-enkephalin (MENK). It focuses on to improve the treatment of cancer, infections, such as human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS), chronic inflammatory diseases and autoimmune diseases.$IMUN